Cercar
01/01/2022
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial (vol 11, pg 187, 2021)
Abbruzzese, G, Kulisevsky, J, Bergmans, B, Gomez-Esteban, JC, Kagi, G, Raw, J, Stefani, A, Warnecke, T, Jost, WH. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial (vol 11, pg 187, 2021). Journal of Parkinsons Disease. 2022; 12(1)DOI:10.3233/JPD-219007. PMID:34275911. IF:5.200(Q1/3D).
24/10/2025
Fatigue and neuropsychiatric symptoms in Parkinson's disease: a narrative review
Bojtos, L, Rodríguez-Antigüedad, J, Pagonabarraga, J, Martínez-Horta, S, Kulisevsky, J. Fatigue and neuropsychiatric symptoms in Parkinson's disease: a narrative review. Frontiers in Neurology. 2025; 16DOI:10.3389/fneur.2025.1670644. PMID:41211291. IF:2.800(Q2/5D).
01/10/2025
The role of endothelial dysfunction in the age-related poor prognosis of stroke patients undergoing endovascular treatment
de la Riva, P, Rodríguez-Antigüedad, J, Marta-Enguita, J, Gómez, V, Arenaza, G, Gorostidi, A, Díez, N, de Arce, A, Garmendia, E, Zumeta, E, Larrea, JA, Bergareche, A, Arregui, ALD. The role of endothelial dysfunction in the age-related poor prognosis of stroke patients undergoing endovascular treatment. Journal of Stroke & Cerebrovascular Diseases. 2025; 34(10)DOI:10.1016/j.jstrokecerebrovasdis.2025.108412. PMID:40769286. IF:1.800(Q3/7D).
01/09/2025
Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy
Lopes, S, Fonseca, V, Pascual-Sedano, B, Simoes, R, Varanda, S, Pagonabarraga, J, Campolongo, A, Rodrigues, M. Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy. PARKINSONISM & RELATED DISORDERS. 2025; 138DOI:10.1016/j.parkreldis.2025.107966. PMID:40763399. IF:3.400(Q2/3D).
25/08/2025
Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models
Di Franco, N, de Tena, IB, Sanchez-Ruiz, A, Pereda-Velarde, A, Enfedaque, F, Gónzalez-Arias, C, Rio, LMM, Bortolozzi, A, Rodriguez-Puertas, R, Costas-Insua, C, Molina-Porcel, L, Vazquez-Oliver, A, Ozaita, A, Guzmán, M, Perea, G, Ginés, S. Restoration of CB1 receptor function in hippocampal GABAergic neurons rescues memory deficits in Huntington's disease models. Translational Neurodegeneration. 2025; 14(1)DOI:10.1186/s40035-025-00500-w. PMID:40855505. IF:15.200(Q1/1D).
20/08/2025
Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial
Rodríguez-Molinero, A, Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Bayes-Rusiñol, A, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martí-Martínez, S, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Tebé, C. Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial. npj Parkinsons Disease. 2025; 11(1)DOI:10.1038/s41531-025-00977-2. PMID:40835832. IF:8.200(Q1/1D).
11/08/2025
Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign
Olmedo-Saura, G, Iruzubieta, P, Bernal, S, Gonzalez-Quereda, L, Pont-Sunyer, C, Navalpotro-Gómez, I, Guisado-Alonso, D, García-Sanchez, C, Rodriguez-Santiago, B, Brais, B, Pagonabarraga, J, Kulisevsky, J, Pérez-Pérez, J. Expanding the clinical-radiological phenotype of SCA34 and its role in the differential diagnosis of the hot cross bun sign. JOURNAL OF NEUROLOGY. 2025; 272(9)DOI:10.1007/s00415-025-13316-5. PMID:40788501. IF:4.600(Q1/2D).
01/08/2025
CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline
Rodriguez-Antiguedad, J, Puig-Davi, A, Ruíz-Barrio, I, Pagonabarraga, J, Vázquez-Oliver, A, Horta-Barba, A, Kulisevsky, J, Martínez-Horta, S. CSF Biomarker-Based Cognitive Trajectories in Parkinson's Disease-Subjective Cognitive Decline. Annals of Clinical and Translational Neurology. 2025; 12(8)DOI:10.1002/acn3.70075. PMID:40501082. IF:3.900(Q1/3D).